1. Home
  2. PTGX vs PSNY Comparison

PTGX vs PSNY Comparison

Compare PTGX & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • PSNY
  • Stock Information
  • Founded
  • PTGX 2006
  • PSNY 2017
  • Country
  • PTGX United States
  • PSNY Sweden
  • Employees
  • PTGX N/A
  • PSNY N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • PSNY Auto Manufacturing
  • Sector
  • PTGX Health Care
  • PSNY Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • PSNY Nasdaq
  • Market Cap
  • PTGX 2.9B
  • PSNY 2.4B
  • IPO Year
  • PTGX 2016
  • PSNY N/A
  • Fundamental
  • Price
  • PTGX $47.47
  • PSNY $1.10
  • Analyst Decision
  • PTGX Strong Buy
  • PSNY Hold
  • Analyst Count
  • PTGX 8
  • PSNY 6
  • Target Price
  • PTGX $66.50
  • PSNY $1.21
  • AVG Volume (30 Days)
  • PTGX 789.1K
  • PSNY 4.8M
  • Earning Date
  • PTGX 05-06-2025
  • PSNY 05-12-2025
  • Dividend Yield
  • PTGX N/A
  • PSNY N/A
  • EPS Growth
  • PTGX N/A
  • PSNY N/A
  • EPS
  • PTGX 0.86
  • PSNY N/A
  • Revenue
  • PTGX $207,801,000.00
  • PSNY $2,034,261,000.00
  • Revenue This Year
  • PTGX N/A
  • PSNY $109.56
  • Revenue Next Year
  • PTGX $50.30
  • PSNY $53.60
  • P/E Ratio
  • PTGX $55.04
  • PSNY N/A
  • Revenue Growth
  • PTGX N/A
  • PSNY N/A
  • 52 Week Low
  • PTGX $27.00
  • PSNY $0.61
  • 52 Week High
  • PTGX $60.60
  • PSNY $1.94
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 58.60
  • PSNY 50.70
  • Support Level
  • PTGX $45.43
  • PSNY $1.00
  • Resistance Level
  • PTGX $46.80
  • PSNY $1.18
  • Average True Range (ATR)
  • PTGX 1.54
  • PSNY 0.07
  • MACD
  • PTGX 0.34
  • PSNY -0.01
  • Stochastic Oscillator
  • PTGX 94.26
  • PSNY 47.87

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

Share on Social Networks: